MENU
+Compare
CABA
Stock ticker: NASDAQ
AS OF
Apr 25 closing price
Price
$1.27
Change
-$0.00 (-0.00%)
Capitalization
64.44M

CABA Cabaletta Bio Forecast, Technical & Fundamental Analysis

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases... Show more

CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CABA with price predictions
Apr 25, 2025

CABA in +14.53% Uptrend, rising for three consecutive days on April 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CABA advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CABA's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on CABA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CABA just turned positive on April 14, 2025. Looking at past instances where CABA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CABA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CABA broke above its upper Bollinger Band on April 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CABA entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.423) is normal, around the industry mean (14.255). P/E Ratio (0.000) is within average values for comparable stocks, (63.920). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.829). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CABA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CABA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CABA is expected to report earnings to -65 cents per share on May 14

Cabaletta Bio CABA Stock Earnings Reports
Q1'25
Est.
$-0.66
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.03
The last earnings report on March 31 showed earnings per share of -64 cents, missing the estimate of -63 cents. With 362.90K shares outstanding, the current market capitalization sits at 64.44M.
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MS116.010.41
+0.35%
Morgan Stanley
NGVT32.880.03
+0.09%
Ingevity Corp
ATKR63.93-0.57
-0.88%
Atkore
ASTS23.76-0.31
-1.29%
AST SpaceMobile
ZVIA2.26-0.11
-4.64%
Zevia PBC

CABA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
N/A
KYTX - CABA
47%
Loosely correlated
-1.87%
IMNM - CABA
44%
Loosely correlated
-1.41%
ARWR - CABA
42%
Loosely correlated
-0.67%
AUTL - CABA
40%
Loosely correlated
-5.00%
PRME - CABA
40%
Loosely correlated
-3.43%
More